A prospective, 96-week study of the impact of Trizivir®, Combivir®/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity

✍ Scribed by PN Kumar; A Rodriguez-French; MA Thompson; KT Tashima; D Averitt; PG Wannamaker; VC Williams; MS Shaefer; GE Pakes; KA Pappa; on behalf of the ESS40002 study team

• Book ID: 111063273
• Publisher: John Wiley and Sons
• Year: 2006
• Tongue: English
• Weight: 206 KB
• Volume: 7
• Category: Article
• ISSN: 1464-2662
• DOI: 10.1111/j.1468-1293.2006.00346.x